Montz et al., "The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model" Am. J. Obstet. Gynecol. 165 (5 Pt. 1):1539-1542 (1991). |
Pados and Devroey, "Adhesions" Curr. Opin. Obstet. Gynecol. 4(3):412-418 (1992). |
Vipond et al., "Experimental adhesion prophylaxis with recombinant tissue plasminogen activator" Ann. R. Coll. Surg. Engl. 76(6):412-415 (1994). |
Wiseman et al., "Fibrinolytic drugs prevent pericardial adhesions in the rabbit" J. Surg. Res. 53:362-368 (1992). |
Bass et al., "Hormone phage: an enrichment method for variant proteins with altered binding properties" Protein: Structure, Function and Genetics 8(4):309-314 (1990). |
Botstein et al., "Strategies and applications of in vitro mutagenesis" Science 229:1193-1201 (1985). |
Bowie et al., "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions" Science 247:1306-1310 (1990). |
Browne et al., "A Tissue-Type Plasminogen Activator Mutant with Prolonged Clearance In Vivo" Journal of Biological Chemistry 263(4):1599-1602 (1988). |
Cambier et al., "Pharmacokinetics and thrombolytic properties of a nonglycosylated mutant of human tissue-type plasminogen activator, lacking the finger and growth factor domains, in dogs with copper coil-induced coronary artery thrombosis" J. Cardiovasc. Pharmacol. 11:468 (1988). |
Caras et al., "Signal for Attachment of a Phospholipid Membrane Anchor in Decay Accelerating Factor" Science 238:1280-1283 (1987). |
Collen et al., "Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits" Blood 71(1):216-219 (Jan. 1988). |
Cwirla et al., "Peptides on phage: a vast library of peptides for identifying ligands" Proc. Natl. Acad. Sci. USA 87(16):6378-6382 (Aug. 1990). |
Dangl et al., "Selection of hybridomas and hybridoma variants using the fluorescence activated cell sorter" J. Immunol. Meth. 52:1-14 (1982). |
de la Cruz et al., "Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage" Journal of Biological Chemistry 263(9):4318-4322 (Mar. 25, 1988). |
Devlin et al., "Random peptide libraries: a source of specific protein binding molecules" Science 249(4967):404-406 (Jul. 27, 1990). |
Geysen, "Antigen -- antibody interactions at the molecular level: adventures in peptide synthesis" Immunology Today 6:364-369 (1985). |
Geysen et al., "A priori delineation of a peptide which mimics a discontinuous antigenic determinant" Molecular Immunology 23(7):709-715 (Jul. 1986). |
Harris, "Second-Generation Plasminogen Activators" Protein Engineering 1(6):449-458 (1987). |
Higgins and Bennett, "Tissue Plasminogen activator: the biochemistry and pharmacology of variants produced by mutagenesis" Ann. Rev. Pharmacol. Toxicol. 30:91-121 (1990). |
Hotchkiss A., et al., "The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator" Thrombosis and Haemostasis 60(2):255-261 (1988). |
Hotchkiss et al., "The activity of a single chain rt-PA mutant in a primates and rabbits" Thromb. Haemost. (Abstract only) 58:491 (1987). |
Johnston et al., "Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting" Proc. Natl. Acad. Sci. USA 80(12):3711-3715 (Jun. 1983). |
Kalyan et al., "Structure-function analysis with tissue-type plasminogen activator" Journal of Biological Chemistry 263:3971-3978 (1988). |
Larsen et al., "Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat" Blood 73:1842-1850 (1989). |
Pannekoek et al., "Mutants of human tissue-type plasminogen activator (t-PA): structural aspects and functional properties" Fibrinolysis 2:123-132 (1988). |
Parmley & Smith, "Antibody-selectable filamentous fd phage vectors: affinity purification of target genes" Gene 73:305-318 (1988). |
Pennica et al., "Cloning and Expression of Human Tissue-type Plasminogen Activator cDNA in E. coli," Nature 301:214-221 (1983). |
Rasched et al., "Ff coliphages: structural and functional relationships" Microbiol. Rev. 50(4):401-427 (Dec. 1986). |
Rice et al, "Measurement of transient cDNA expression in mammalian cells using flow cytometric cell analysis and sorting" Cytometry 12:221-233 (1991). |
Rijken and Collen, "Purification and Characterization of the Plasminogen Activator Secreted by Human Melanoma Cells in Culture," Journal of Biological Chemistry 256(13):7035-7041 (1981). |
Ross et al., "Plasminogen Activators" Annual Reports in Medicinal Chemistry, Chapter 12, 23:111-120 (1988). |
Schroff et al., "Detection of intracytoplasmic antigens by flow cytometry" J. Immunol. Methods 70(2):167-177 (May 25, 1984). |
Scott et al., "Searching for peptide ligands with an epitope library" Science 24(4967)):386-390 (Jul. 27, 1990). |
Shortle Protein Engineering, Oxender & Fox (eds.), New York:A.R. Liss, Inc. pp. 103-108 (1985). |
Smith, "Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface" Science 228(4705):1315-1317 (Jun. 14, 1985). |
Ikenaka, Y. et al. Blood Coagulation & Fibrinolysis 3:381-387 (1992). |